News

Research

AI Opens Door to Safe, Effective New Antibiotics to Combat Resistant Bacteria

Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.

Newsletter

John F. Brooks II to Present 2024 Richard J. Meyer Lecture Nov. 8

Dr. Brooks’ research focuses on the circadian clock regulation of host-microbe dynamics.

Dr. John F. Brooks II, Assistant Professor of Molecular Biology at Princeton University, will present the 2024 Richard J. Meyer Lecture.

Newsletter

Andrew Pekosz Addresses Influenza Mutations at 2024 LaMontagne Symposium

The title of Dr. Pekosz's lecture was "Virus Surveillance and the Identification of Novel Genetic Mutations that Facilitate Virus Circulation."

Pekosz with Dudley and La Montagnes

Announcements

In Memoriam: Walter L. Fast

Walter L. Fast, LCID Faculty member and Pharmacy professor, passed away on December 4, 2023 after a brief illness.

Walter Fast

Accolades

Dudley Elected Fellow of the American Association for the Advancement of Science

LCID Associate Director Dr. Jaquelin Dudley was recently elected a Fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general...

Jaquelin Dudley

Newsletter

Simon Draper Presents Inaugural Richard J. Meyer Endowed Lecture

The title of Dr. Draper’s lecture was Advances in Vaccines and Antibodies for Blood-Stage Human Malaria.

Headshot of Simon Draper

Department of Molecular Biosciences

McLellan Named Recipient of the 2024 IVI-SK Bioscience Park MahnHoon Award

The International Vaccine Institutes Bioscience Park MahnHoon Award recognizes his role in the development of several vaccines.

Research

Alzheimer’s Drug Fermented With Help From AI and Bacteria Moves Closer to Reality

An innovative approach uses artificial intelligence and biosensors to pave the way for faster drug development.

UT News

Cancer Prevention, Screening and Research Programs Expanding With CPRIT Support

Yi Lu and Lauren Ehrlich of the College of Natural Sciences are among the cancer researchers with exciting projects on the horizon.

Research

Increased Use of Paxlovid Could Cut Hospitalizations, Deaths and Costs

Epidemiologists found that treating even 20% of symptomatic cases would save lives and improve public health.